Matinas Biopharma Holdings Inc. (MTNB)
Market Closed
17 Jul, 20:00
AMEX AMEX Primary $
0. 34
-0.01
-3.6415%
$
2.67M Market Cap
- P/E Ratio
- Div Yield
569,300 Volume
- Eps
$ 0.36
Previous Close 
Want to track MTNB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Matinas BioPharma Holdings, Inc. (MTNB) Q2 2024 Earnings Call Transcript
Matinas BioPharma Holdings, Inc. (NYSE:MTNB ) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Jody Cain – LHA Investor Relations Jerry Jabbour – Chief Executive Officer Keith Kucinski – Chief Financial Officer Terri Matkovits – Chief Development Officer Conference Call Participants Scott Henry – Alliance Global Partners Joanne Lee – Maxim Group Operator Welcome to the Matinas BioPharma Second Quarter 2024 Financial Results Conference Call. Currently all participants are in a listen-only mode.
Seekingalpha | 1 year ago
